GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BIO-FD&C Co Ltd (XKRX:251120) » Definitions » Accounts Payable & Accrued Expense

BIO-FD&C Co (XKRX:251120) Accounts Payable & Accrued Expense : ₩1,636 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is BIO-FD&C Co Accounts Payable & Accrued Expense?

BIO-FD&C Co's quarterly accounts payable & accrued expense increased from Sep. 2023 (₩1,288 Mil) to Dec. 2023 (₩1,673 Mil) but then declined from Dec. 2023 (₩1,673 Mil) to Mar. 2024 (₩1,636 Mil).

BIO-FD&C Co's annual accounts payable & accrued expense increased from Dec. 2020 (₩702 Mil) to Dec. 2021 (₩2,237 Mil) but then declined from Dec. 2021 (₩2,237 Mil) to Dec. 2022 (₩1,487 Mil).


BIO-FD&C Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for BIO-FD&C Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BIO-FD&C Co Accounts Payable & Accrued Expense Chart

BIO-FD&C Co Annual Data
Trend Dec15 Dec16 Dec18 Dec19 Dec20 Dec21 Dec22
Accounts Payable & Accrued Expense
Get a 7-Day Free Trial 113.26 315.12 701.68 2,237.25 1,487.21

BIO-FD&C Co Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,362.25 1,293.19 1,288.30 1,672.65 1,636.20

BIO-FD&C Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.


BIO-FD&C Co (XKRX:251120) Business Description

Industry
Traded in Other Exchanges
N/A
Address
30, Songdomirae-ro, Yeonsu-gu, 509-512, B07, A-dong, Smartvalley, Incheon, KOR
BIO-FD&C Co Ltd is engaged in dealing with anti-aging and health materials using sustainable bio-cultivation technology. Its products include Plant cell, Peptide, Herbal Extract and Biomolecule.

BIO-FD&C Co (XKRX:251120) Headlines

No Headlines